연구성과로 돌아가기
JCR 2023 저널 목록 (862 / 2065)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Techniques in Coloproctology | SPRINGER-VERLAG ITALIA SRL | 1123-6337 | 1128-045X | SCIE | GASTROENTEROLOGY & HEPATOLOGY | 3,462 | 2.7 | Q2 | 44.4 | 55.6 | 64/143 | 3.2 | Q2 | 2.5 | 0.6 | 0.88 | 37/143 | Q2 | 74.48 | 0.004 | 0.956 | 0.872 | Q2 | 94 | 77.7% | 5.1 | 7.1 | 73 | 25.8% | 2025-03-24 17:14:59 | 바로가기 |
| Topological Methods in Nonlinear Analysis | NICOLAUS COPERNICUS UNIV TORUN, JULIUSZ SCHAUDER CTR NONLINEAR STUDIES | 1230-3429 | 1230-3429 | SCIE | MATHEMATICS | 872 | 0.7 | Q2 | 44.4 | 55.6 | 218/490 | 0.7 | Q2 | 0.7 | 0.2 | 0.54 | 274/490 | Q3 | 44.18 | 0.001 | 0.260 | 0.405 | Q3 | 44 | 100.0% | 9.6 | 17.3 | 44 | 68.1% | 2025-03-24 17:28:11 | 바로가기 |
| WEB ECOLOGY | COPERNICUS GESELLSCHAFT MBH | 2193-3081 | 1399-1183 | SCIE | ECOLOGY | 235 | 2.3 | Q2 | 44.4 | 55.6 | 88/197 | 2.1 | Q3 | 2.3 | 0.4 | 0.53 | 114/197 | Q3 | 42.39 | 0.000 | 0.047 | 0.508 | Q3 | 8 | 100.0% | 6.3 | 10.0 | 8 | 100.0% | 2025-03-24 17:04:36 | 바로가기 |
| ZEITSCHRIFT FUR ANALYSIS UND IHRE ANWENDUNGEN | EUROPEAN MATHEMATICAL SOC-EMS | 0232-2064 | 1661-4534 | SCIE | MATHEMATICS | 520 | 0.7 | Q2 | 44.4 | 55.6 | 218/490 | 0.7 | Q2 | 0.7 | 0.2 | 0.67 | 201/490 | Q2 | 59.08 | 0.000 | 0.099 | 0.458 | Q2 | 24 | 100.0% | 17.2 | 12.7 | 24 | 0.0% | 2025-03-24 17:28:20 | 바로가기 |
| American Journal of Cardiovascular Drugs | ADIS INT LTD | 1175-3277 | 1179-187X | SCIE | PHARMACOLOGY & PHARMACY | 1,508 | 2.8 | Q2 | 44.5 | 55.5 | 158/354 | 2.6 | Q3 | 2.7 | 0.6 | 0.70 | 164/354 | Q2 | 53.81 | 0.002 | 0.367 | 0.716 | Q2 | 56 | 51.8% | 5.9 | 6.5 | 29 | 29.0% | 2025-03-24 17:36:37 | 바로가기 |
| Australian Critical Care | ELSEVIER SCIENCE INC | 1036-7314 | 1878-1721 | SCIE | CRITICAL CARE MEDICINE | 1,879 | 2.6 | Q2 | 44.5 | 55.5 | 25/55 | 3.0 | Q2 | 2.2 | 1.6 | 1.09 | 10/55 | Q1 | 82.73 | 0.002 | 0.540 | 0.827 | Q2 | 141 | 79.4% | 4.1 | 7.6 | 112 | 16.7% | 2025-03-24 17:03:19 | 바로가기 |
| BIOSYSTEMS | ELSEVIER SCI LTD | 0303-2647 | 1872-8324 | SCIE | BIOLOGY | 3,323 | 2.0 | Q2 | 44.5 | 55.5 | 49/109 | 1.8 | Q3 | 1.4 | 0.5 | 0.60 | 46/109 | Q2 | 58.26 | 0.002 | 0.407 | 0.361 | Q3 | 158 | 96.2% | 9.7 | 10.9 | 152 | 18.3% | 2025-03-24 16:56:35 | 바로가기 |
| BJA Education | ELSEVIER SCI LTD | 2058-5349 | 2058-5357 | ESCI | ANESTHESIOLOGY | 2,050 | 1.7 | Q2 | 44.5 | 55.5 | 29/64 | 2.5 | Q2 | 1.6 | 0.4 | 0.64 | 30/64 | Q2 | 53.91 | 0.002 | 0.406 | 0.728 | Q2 | 48 | 100.0% | 7.2 | 6.8 | 48 | 10.6% | 2025-03-24 16:53:26 | 바로가기 |
| BMC Pharmacology & Toxicology | BMC | N/A | 2050-6511 | SCIE | PHARMACOLOGY & PHARMACY | 1,947 | 2.8 | Q2 | 44.5 | 55.5 | 158/354 | 2.7 | Q3 | 2.8 | 0.4 | 0.79 | 130/354 | Q2 | 63.42 | 0.002 | 0.455 | 0.587 | Q3 | 73 | 87.7% | 5.0 | 7.5 | 64 | 99.6% | 2025-03-24 17:36:34 | 바로가기 |
| Brazilian Journal of Anesthesiology | ELSEVIER SCIENCE INC | 0104-0014 | 2352-2291 | SCIE | ANESTHESIOLOGY | 467 | 1.7 | Q2 | 44.5 | 55.5 | 29/64 | 1.7 | Q3 | 1.6 | 0.9 | 0.69 | 29/64 | Q2 | 55.47 | 0.001 | 0.155 | 0.388 | Q3 | 102 | 84.3% | 1.8 | 9.6 | 86 | 98.1% | 2025-03-24 16:53:28 | 바로가기 |
| BULLETIN OF MATHEMATICAL BIOLOGY | SPRINGER | 0092-8240 | 1522-9602 | SCIE | BIOLOGY | 5,575 | 2.0 | Q2 | 44.5 | 55.5 | 49/109 | 2.1 | Q2 | 1.9 | 0.5 | 0.86 | 30/109 | Q2 | 72.94 | 0.004 | 0.874 | 0.673 | Q2 | 121 | 96.7% | 13.0 | 10.1 | 117 | 36.1% | 2025-03-24 16:56:33 | 바로가기 |
| Chinese Journal of Traumatology | ELSEVIER INC | 1008-1275 | 1008-1275 | ESCI | ORTHOPEDICS | 1,436 | 1.8 | Q2 | 44.5 | 55.5 | 61/136 | 2.1 | Q2 | 1.7 | 0.6 | 0.79 | 58/136 | Q2 | 57.72 | 0.001 | 0.318 | 0.508 | Q3 | 59 | 79.7% | 5.7 | 8.5 | 47 | 96.9% | 2025-03-24 17:34:59 | 바로가기 |
| CHIRALITY | WILEY | 0899-0042 | 1520-636X | SCIE | PHARMACOLOGY & PHARMACY | 3,432 | 2.8 | Q2 | 44.5 | 55.5 | 158/354 | 2.2 | Q3 | 2.6 | 1.0 | 0.60 | 201/354 | Q3 | 43.36 | 0.002 | 0.382 | 0.400 | Q3 | 90 | 90.0% | 9.6 | 9.0 | 81 | 15.0% | 2025-03-24 17:36:26 | 바로가기 |
| Clinics in Shoulder and Elbow | Korean Shoulder and Elbow Soc | 2288-8721 | 2288-8721 | ESCI | ORTHOPEDICS | 353 | 1.8 | Q2 | 44.5 | 55.5 | 61/136 | N/A | N/A | 1.7 | 0.9 | 0.86 | 47/136 | Q2 | 65.81 | 0.001 | 0.167 | N/A | N/A | 58 | 89.7% | 2.6 | 8.8 | 52 | 100.0% | 2025-03-24 17:35:04 | 바로가기 |
| Current Developmental Disorders Reports | SPRINGERNATURE | N/A | 2196-2987 | ESCI | PSYCHOLOGY, DEVELOPMENTAL | 677 | 2.2 | Q2 | 44.5 | 55.5 | 41/91 | N/A | N/A | 2.1 | 0.7 | 0.61 | 65/91 | Q3 | 29.12 | 0.001 | 0.181 | N/A | N/A | 21 | 42.9% | 5.9 | 7.6 | 9 | 18.8% | 2025-03-24 17:58:03 | 바로가기 |
페이지 이동: